K

Kineta

30 employees

Kineta aims at developing edge therapeutics in autoimmune disease, viral disease, and chronic pain areas.

Basic info

Industry

biotechnology research

Sectors

Biodefense
Medical Device
Biotechnology
Neuroscience
Lassa fever
Immunology
Antivirals
Therapeutics
Immuno-oncology
Virology
Chronic Pain

Date founded

2008

Funding rounds raised

Total raised

$17M

from 8 investors over 8 rounds

K

Kineta raised $6M on April 20, 2023

Investors: Keiretsu Capital

K

Kineta raised $17M on June 1, 2021

Investors: CBI Co Ltd

K

Kineta raised $5M on May 5, 2020

Investors: Scott • Schlaepfer Family Foundation and Keiretsu Capital

K

Kineta raised $1.8M on August 6, 2019

Investors: Wellcome Trust

K

Kineta raised $45K on May 9, 2019

Investors: Keiretsu Capital and SFC Capital

K

Kineta raised $5M on September 11, 2017

Investors: Keiretsu Capital

FAQ